Search the web
Sign In
New User? Sign Up
nathanfaustmantrials · JoinLeeNow Nathan/Faustman Trials Group
? Already a member? Sign in to Yahoo!

Yahoo! Groups Tips

Did you know...
Want your group to be featured on the Yahoo! Groups website? Add a group photo to Flickr.

Best of Y! Groups

   Check them out and nominate your group.
Having problems with message search? Fill out this form to ensure your group is one of the first to be migrated to the new message search system.

Messages

  Messages Help
Advanced
NEJM Correspondence   Message List  
Reply | Forward Message #257 of 634 |
Re: NEJM Correspondence

Forget about the fundraisers jumping on board at that point. IF BCG
halts the autoimmune attach I would like to see the government step
in an recognize that curing major disease is with our reach and let
them DO SOMETHING to advance the research!!!

--- In nathanfaustmantrials@yahoogroups.com, "rmccully2000"
<rmccully2000@...> wrote:
>
>
> Perhaps if BCG is successful in temporarily halting the autoimmune
> attack, then millions of the research money raised would start
> funnelling into the search for the second compound? Hopefully the
> fundraising machines will jump on board at that point.
>
> Regardless, even if it did take that long for a permanent solution,
> this would still be 10 - 15 years that my son will not have to take
> insulin, count carbs, wear sensors and insulin pumps, carry
glucagon,
> meters, strips, poker and glucose tabs, go to the nurse as often,
> etc. etc. etc.
>
> Becky, Mom to Mason, 7
>
> --- In nathanfaustmantrials@yahoogroups.com, "stilltypeone"
> <stilltypeone@> wrote:
> >
> > From Lynne Murphy at MGH:
> >
> > "Keep checking our website www.faustmanlab.org for updated
> > information. We will also be informing all individuals in our
> > database when the clinical trial is about to start. I think we
are
> > planning for early 2008."
> >
> > I believe this is for the BCG arm of the trial only. They have
yet
> > to identify the second agent, to make this "cure" permanent.
> >
> > Possibly another 10 to 15 years to identify the second agent?
> >
> >
> > --- In nathanfaustmantrials@yahoogroups.com, "imcimc1"
> > <curtieimc@> wrote:
> > >
> > >
> > > Go the below website and lok on the right hand side
> > under "Contact" and
> > > it will give you information on who to contact about the trials.
> > >
> > > http://www.faustmanlab.org <http://www.faustmanlab.org>
> > >
> > >
> > >
> > >
> > > --- In nathanfaustmantrials@yahoogroups.com, "mjspicer51"
> > > <mjspicer51@> wrote:
> > > >
> > > > I am new to this group. I have been waiting for 20+ years to
> see
> > a
> > > > cure or a real hope of a cure...What is happening seems to be
> > faster
> > > > than the ADA who seems satisfied with the band aid of using
> > insulin
> > > > instead of finding a real cure. How do I get my name on the
list
> > > > for the trials? I have two grandsons who I hope never have to
> > deal
> > > > with this desease personally. Thank you, would love to hear
from
> > > > anyone on this situation --- In
> > > > nathanfaustmantrials@yahoogroups.com, "imcimc1" curtieimc@
> > > > wrote:
> > > > >
> > > > > They have to automate the process. They cannot monitor even
a
> > > > small
> > > > > group of people effectively day after day during the trial
> > without
> > > > > automation. I would rather see this automation process get
off
> > > > the
> > > > > ground now instead of after phase 1 of the trial is
finished.
> > At
> > > > > least the are working with some kind of vision and greater
> > plan in
> > > > > mind. My fingers are crossed with this one.
> > > > >
> > > > > --- In nathanfaustmantrials@yahoogroups.com, "stilltypeone"
> > > > > <stilltypeone@> wrote:
> > > > > >
> > > > > > Sue, thanks for the info. I am still baffled that they
> chose
> > to
> > > > > > spend time and money on the automation process, when it
may
> > be a
> > > > > > moot point.
> > > > > > If they can count T cells from hundreds of mice, can they
> > not do
> > > > > the
> > > > > > same for such a small sample of humans?
> > > > > >
> > > > > >
> > > > > > --- In nathanfaustmantrials@yahoogroups.com, Sue root
> > > > > > <susan_root@> wrote:
> > > > > > >
> > > > > > > The procedure to separate and count the targeted T
cells
> > from
> > > > > > whole blood samples in humans takes 1 ½ days by hand.
Seeing
> > > > that
> > > > > > they plan to ultimately take blood samples every other
day
> > from
> > > > the
> > > > > > patients to monitor the effect, and they will plan to
have
> 40
> > > > > > patients in the trial with controls, the automation will
> make
> > > > this
> > > > > > possible in a timely manner by decreasing the procedure
to
> > only
> > > > > > about 6 hrs. More importantly, standardizing dosing in
mice
> > is
> > > > much
> > > > > > less of an issue compared to humans, even if we're
talking
> 40
> > > > people
> > > > > > > Even though the NOD mouse is the best known animal
model
> > for
> > > > type
> > > > > > I diabetes, when dosing in mice, one doesn't have to deal
> > with
> > > > > > variables such as body weight. The groups of mice are
born
> at
> > > > the
> > > > > > same time, are the same size, and develop diabetes
roughly
> > the
> > > > same
> > > > > > time. Therefore, being able to standardize the dosing of
> BCG
> > in
> > > > a
> > > > > > group of humans with such variables, will be a key factor
> for
> > > > > > success.
> > > > > > > What we do know is that the NOD mice have the same 2
> > defects
> > > > > > found in humans with type I diabetes and the treatment
that
> > Dr.
> > > > > > Faustman used targets and eliminates these defects.
> > > > > > >
> > > > > > >
> > > > > > > stilltypeone <stilltypeone@> wrote:
> > > > > > > Patsy, I think you are misunderstanding what I am
> > > > > > inferring.
> > > > > > > The point I am making is why spend so much time and
money
> > on a
> > > > > > > automation process that, in the end may end up as
useless.
> > > > Kind
> > > > > of
> > > > > > > like the "cart before the horse". Why not do the
initial
> > trial
> > > > by
> > > > > > > hand, as the mouse trials were done. If sucessful, then
> > move
> > > > on
> > > > > to
> > > > > > > scale this up to a larger group trial.
> > > > > > > I would not expect death from BCG injections, as it is
> > used in
> > > > > > huge
> > > > > > > quantities for bladder cancer.
> > > > > > > The begining trial as I understand it will be 40
> > individuals.
> > > > I
> > > > > > > consider that "small". I realize that is a relative
term.
> > > > > > > If asking questions is "grumbling" then I am guilty.
> > > > > > >
> > > > > > > --- In nathanfaustmantrials@yahoogroups.com, Patsy Van
> > Huyck
> > > > > > > <patsy@> wrote:
> > > > > > > >
> > > > > > > > The answer in short is because if a mouse dies, nobody
> > > > cares.
> > > > > > > Just
> > > > > > > > think if the "small human trial" was a failure either
> > due to
> > > > > > huge
> > > > > > > > complications or due to the lack of results. Do you
> think
> > > > that
> > > > > > > they
> > > > > > > > would just get to try again with another dose? The
> assay
> > is
> > > > > very
> > > > > > > > important so that the trial can be successful, and we
> can
> > > > then
> > > > > > > move to
> > > > > > > > the next stage.
> > > > > > > >
> > > > > > > > We all want the cure to have been in 2002, but
dealing
> > with
> > > > the
> > > > > > > FDA is
> > > > > > > > tediously slow. Grumbling isn't going to get the
> research
> > > > done
> > > > > > > any more
> > > > > > > > quickly.
> > > > > > > >
> > > > > > > > Patsy
> > > > > > > >
> > > > > > > > >
> > > > > > > > > Re: NEJM Correspondence
> > > > > > > > >
> > > > > > >
> > > > > >
> > > > >
> > > >
> >
>
<http://groups.yahoo.com/group/nathanfaustmantrials/message/245;_ylc=
> > > > > > >
> > > > > >
> > > > >
> > > >
> >
>
X3oDMTJxMmg3MXB1BF9TAzk3MzU5NzE1BGdycElkAzE2NDEyMTQ1BGdycHNwSWQDMTcwN
> > > > > > >
> > > > > >
> > > > >
> > > >
> >
>
TA2MTY2MgRtc2dJZAMyNDUEc2VjA2Rtc2cEc2xrA3Ztc2cEc3RpbWUDMTE3MDU4NDUyMQ
> > > > > > > -->
> > > > > > > > >
> > > > > > > > >
> > > > > > > > >
> > > > > > > > > Posted by: "stilltypeone" stilltypeone@
> > > > > > > > > <mailto:stilltypeone@?Subject=%20Re%3A%20NEJM%
> > > > > > > 20Correspondence>
> > > > > > > > > stilltypeone
<http://profiles.yahoo.com/stilltypeone>
> > > > > > > > >
> > > > > > > > >
> > > > > > > > > Sat Feb 3, 2007 6:57 pm (PST)
> > > > > > > > >
> > > > > > > > > Sue, can we agree that these trials will not
proceed
> > until
> > > > > > > > > the "automated assay" is completed?
> > > > > > > > > Did Faustman have this automated assay during the
> mouse
> > > > > trials?
> > > > > > > > > I am guessing the answer is no.
> > > > > > > > > So, why the need for automation for a small human
> > trial?
> > > > > > > >
> > > > > > >
> > > > > >
> > > > >
> > > >
> > >
> >
>





Thu Mar 8, 2007 8:44 pm

imcimc1
Offline Offline
Send Email Send Email

Forward
Message #257 of 634 |
Expand Messages Author Sort by Date

In the most recent edition of the New England Journal of Medicine (NEJM), a letter from Dr. Faustman written in response to a letter to the NEJM from Douglas...
Scott Strumello
sstrumello
Offline Send Email
Jan 31, 2007
9:50 pm

What will be different in Dr. Faustman and Dr. Nathan's human clinical trial is that they will be using multiple dosing of BCG in humans at an increasing...
Sue root
susan_root
Offline Send Email
Feb 1, 2007
7:44 pm

Sue, can we agree that these trials will not proceed until the "automated assay" is completed? Did Faustman have this automated assay during the mouse trials? ...
stilltypeone
Offline Send Email
Feb 4, 2007
2:57 am

The answer in short is because if a mouse dies, nobody cares. Just think if the "small human trial" was a failure either due to huge complications or due to...
Patsy Van Huyck
PatsyVanHuyck
Offline Send Email
Feb 4, 2007
4:36 pm

Patsy, I think you are misunderstanding what I am inferring. The point I am making is why spend so much time and money on a automation process that, in the end...
stilltypeone
Offline Send Email
Feb 8, 2007
1:52 pm

The procedure to separate and count the targeted T cells from whole blood samples in humans takes 1 ½ days by hand. Seeing that they plan to ultimately take...
Sue root
susan_root
Offline Send Email
Feb 8, 2007
7:12 pm

Sue, thanks for the info. I am still baffled that they chose to spend time and money on the automation process, when it may be a moot point. If they can count...
stilltypeone
Offline Send Email
Feb 13, 2007
2:38 am

They have to automate the process. They cannot monitor even a small group of people effectively day after day during the trial without automation. I would...
imcimc1
Offline Send Email
Feb 13, 2007
10:24 pm

I am new to this group. I have been waiting for 20+ years to see a cure or a real hope of a cure...What is happening seems to be faster than the ADA who seems...
mjspicer51
Offline Send Email
Feb 15, 2007
1:48 pm

Go the below website and lok on the right hand side under "Contact" and it will give you information on who to contact about the trials. ...
imcimc1
Offline Send Email
Feb 15, 2007
3:30 pm

From Lynne Murphy at MGH: "Keep checking our website www.faustmanlab.org for updated information. We will also be informing all individuals in our database...
stilltypeone
Offline Send Email
Mar 1, 2007
1:33 pm

If BCG is successful and safe, I would welcome taking it every day until the second agent is identified. We need a cure NOW. This is an absolutely miserable...
imcimc1
Offline Send Email
Mar 1, 2007
7:15 pm

Perhaps if BCG is successful in temporarily halting the autoimmune attack, then millions of the research money raised would start funnelling into the search...
rmccully2000
Offline Send Email
Mar 2, 2007
8:58 pm

Forget about the fundraisers jumping on board at that point. IF BCG halts the autoimmune attach I would like to see the government step in an recognize that...
imcimc1
Offline Send Email
Mar 8, 2007
10:13 pm

What second agent? Are you talking about the second arm of the research, where they plan to add healthy tissue matching spleen cells? Patsy...
Patsy Van Huyck
PatsyVanHuyck
Offline Send Email
Mar 2, 2007
6:51 pm
Advanced

Copyright © 2009 Yahoo! Inc. All rights reserved.
Privacy Policy - Terms of Service - Guidelines - Help